ANNA GUT: Open Payments
NPI 1740611748 · TRUMBULL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 16 payments from 9 companies in 2025. Trend: 2023 $2,352 · 2024 $1,627 · 2025 $1,848
Food & beverage: $1,848
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $365 |
| Axsome Therapeutics, Inc. | 3 | $362 |
| ABBVIE INC. | 2 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $232 |
| Alkermes, Inc. | 2 | $226 |
| TMS NeuroHealth Centers Inc. | 1 | $144 |
| Lilly USA, LLC | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: Auvelity, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, LYBALVI, TMS NeuroHealth Centers Inc., ZEPBOUND, COBENFY.
Industry payments across CT — which companies pay providers there.
